Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Schizophrenia

Free Subscription 01.06.2026 4 Br J Psychiatry 1 J Clin Psychopharmacol 1 Neuropsychopharmacology 1 Pharmacopsychiatry 4 Psychol Med 5 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Br J Psychiatry

1. ABBOUD F, Ahrens J, Balles E, Bambini V, et al
   The functional relevance of a short assessment of formal thought disorder in psychosis.
   Br J Psychiatry. 2026 May 26:1-9. doi: 10.1192/bjp.2026.10650.
   PubMed         Abstract available
   
   
2. GHENCIULESCU A, Pearse A, Minichino A, Sampogna G, et al
   Transdiagnostic efficacy of lurasidone on depressive symptoms: systematic review and meta-analysis of randomised controlled trials.
   Br J Psychiatry. 2026;228:357-366.
   PubMed         Abstract available
   
   
3. WAGNER E, Korman N, Solmi M, Mortazavi M, et al
   Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis.
   Br J Psychiatry. 2026;228:348-356.
   PubMed         Abstract available
   
   
4. LAUNDERS N, Jackson CA, Hayes JF, John A, et al
   Characteristics of people with severe mental illness excluded from incentivised physical health checks in the UK: electronic healthcare record study.
   Br J Psychiatry. 2026;228:340-347.
   PubMed         Abstract available
   
   

   
   J Clin Psychopharmacol

5. MISAWA F, Takeuchi H
   Therapeutic Interventions and Clinical Outcomes Following Breakthrough Psychosis on Antipsychotic Maintenance Medication (BAMM): A Retrospective Chart Review.
   J Clin Psychopharmacol. 2026 May 28. doi: 10.1097/JCP.0000000000002196.
   PubMed         Abstract available
   
   

   
   Neuropsychopharmacology

6. PARKER N, Koch E, Shadrin AA, Fuhrer J, et al
   Leveraging the genetics of psychiatric disorders to prioritize potential drug targets and compounds.
   Neuropsychopharmacology. 2026;51:1300-1309.
   PubMed         Abstract available
   
   

   
   Pharmacopsychiatry

7. ACUNA M, Martin-Munoz JC, Munoz MJ, Casado FD, et al
   A Naturalistic Study on the Cost Reduction and Efficacy of Long-acting Antipsychotics in an Early Intervention Programme for Patients with Recent-onset Psychosis.
   Pharmacopsychiatry. 2026 May 29. doi: 10.1055/a-2865-3839.
   PubMed         Abstract available
   
   

   
   Psychol Med

8. UNZUETA J, Mathias S, Lanzagorta N, Mollon J, et al
   Evaluating psychosis-specific effects of trauma exposure in early-onset and adult-onset psychosis.
   Psychol Med. 2026;56:e168.
   PubMed         Abstract available
   
   
9. TAKEKITA Y, Katsumoto E, Adachi N, Kubota Y, et al
   Factors associated with social functioning by relapse frequency in Japanese outpatients with schizophrenia: the Multicenter Treatment Survey and Assessments for Schizophrenia in Psychiatric Clinics (MUSASI).
   Psychol Med. 2026;56:e159.
   PubMed         Abstract available
   
   
10. CHEN PC, Pan YJ, Lin MC, Su MH, et al
    Familial coaggregation and shared genetic loading of mental disorders and cardiovascular diseases.
    Psychol Med. 2026;56:e164.
    PubMed         Abstract available
    
    
11. LU C, Dong Y, Zhai Z, Gao T, et al
    Predicting functional remission after antipsychotic discontinuation: a real-world study in schizophrenia.
    Psychol Med. 2026;56:e167.
    PubMed         Abstract available
    
    

    
    Schizophr Res

12. CRABTREE E, Brock E, Lewandowski KE
    Elevated impulsivity in psychosis is associated with mood, anxiety, and general symptoms.
    Schizophr Res. 2026;295:120-128.
    PubMed         Abstract available
    
    
13. LINDENMAYER JP, Khan A, Insel BJ, Kothare H, et al
    Psychometric analysis of speech-based digital biomarkers of alogia symptoms in treatment resistant schizophrenia: Comparison with clinical ratings of expressive negative symptoms.
    Schizophr Res. 2026;295:110-119.
    PubMed         Abstract available
    
    
14. ATAOV G, Balaban OD, Cirakli Z, Yesilkaya UH, et al
    Can electroconvulsive therapy attenuate glial stress in schizophrenia? Longitudinal evidence from serum GFAP and S100B.
    Schizophr Res. 2026;295:91-100.
    PubMed         Abstract available
    
    
15. HOLKER J, Clouse A, Gilday SAJ, Jensen J, et al
    Motivation and pleasure deficits reflect altered network embedding of normal brain deviations in schizophrenia.
    Schizophr Res. 2026;295:82-90.
    PubMed         Abstract available
    
    
16. WU M, Li Z, Wang Y, Zhang X, et al
    A network analysis of psychotic symptoms, neurocognition, alexithymia, empathy, and suicidal intent in patients with chronic schizophrenia.
    Schizophr Res. 2026;295:72-81.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum